IRTC saw its Momentum Indicator move above the 0 level on October 19, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 87 similar instances where the indicator turned positive. In 72 of the 87 cases, the stock moved higher in the following days. The odds of a move higher are at 83%.
The Moving Average Convergence Divergence (MACD) for IRTC just turned positive on October 15, 2026. Looking at past instances where IRTC's MACD turned positive, the stock continued to rise in 38 of 48 cases over the following month. The odds of a continued upward trend are 79%.
IRTC moved above its 50-day moving average on October 22, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for IRTC crossed bullishly above the 50-day moving average on October 28, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 10 of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 62%.
Following a +3.27% 3-day Advance, the price is estimated to grow further. Considering data from situations where IRTC advanced for three days, in 255 of 323 cases, the price rose further within the following month. The odds of a continued upward trend are 79%.
The 10-day RSI Indicator for IRTC moved out of overbought territory on October 30, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 32 similar instances where the indicator moved out of overbought territory. In 26 of the 32 cases, the stock moved lower in the following days. This puts the odds of a move lower at 81%.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 9 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where IRTC declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 80%.
IRTC broke above its upper Bollinger Band on October 22, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for IRTC entered a downward trend on October 15, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Valuation Rating of 3 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: IRTC's P/B Ratio (21.866) is slightly higher than the industry average of (4.209). IRTC's P/E Ratio (-293.738) is considerably lower than the industry average of (1.433). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (11.253). Dividend Yield (0.000) settles around the average of (0.010) among similar stocks. P/S Ratio (4.398) is also within normal values, averaging (40.124).
The Tickeron Seasonality Score of 10 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is 51 (best 1 - 100 worst), indicating steady price growth. IRTC’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 58 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 62 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock slightly better than average.
The Tickeron SMR rating for this company is 93 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 16 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +0.87% 3-day Advance, the price is estimated to grow further. Considering data from situations where RVP advanced for three days, in 186 of 276 cases, the price rose further within the following month. The odds of a continued upward trend are 67%.
RVP may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Momentum Indicator moved below the 0 level on October 01, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on RVP as a result. In 70 of 91 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 77%.
RVP moved below its 50-day moving average on October 05, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for RVP crossed bearishly below the 50-day moving average on October 02, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 14 of 16 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 88%.
The 50-day moving average for RVP moved below the 200-day moving average on October 19, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where RVP declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 82%.
The Aroon Indicator for RVP entered a downward trend on October 27, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Valuation Rating of 18 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.233) is normal, around the industry mean (4.882). P/E Ratio (-4.708) is within average values for comparable stocks, (38.076). Projected Growth (PEG Ratio) (0.010) is also within normal values, averaging (4.143). Dividend Yield (0.000) settles around the average of (0.005) among similar stocks. P/S Ratio (0.600) is also within normal values, averaging (56.876).
The Tickeron PE Growth Rating for this company is 24 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 75 (best 1 - 100 worst), indicating slightly worse than average price growth. RVP’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 92 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. RVP’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.
IRTC | RVP | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 50 | 50 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 3 Undervalued | 18 Undervalued | |
PROFIT vs RISK RATING 1..100 | 62 | 100 | |
SMR RATING 1..100 | 93 | 92 | |
PRICE GROWTH RATING 1..100 | 51 | 75 | |
P/E GROWTH RATING 1..100 | 58 | 24 | |
SEASONALITY SCORE 1..100 | 10 | 90 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
IRTC's Valuation (3) in the Medical Specialties industry is in the same range as RVP (18). This means that IRTC’s stock grew similarly to RVP’s over the last 12 months.
IRTC's Profit vs Risk Rating (62) in the Medical Specialties industry is somewhat better than the same rating for RVP (100). This means that IRTC’s stock grew somewhat faster than RVP’s over the last 12 months.
RVP's SMR Rating (92) in the Medical Specialties industry is in the same range as IRTC (93). This means that RVP’s stock grew similarly to IRTC’s over the last 12 months.
IRTC's Price Growth Rating (51) in the Medical Specialties industry is in the same range as RVP (75). This means that IRTC’s stock grew similarly to RVP’s over the last 12 months.
RVP's P/E Growth Rating (24) in the Medical Specialties industry is somewhat better than the same rating for IRTC (58). This means that RVP’s stock grew somewhat faster than IRTC’s over the last 12 months.
| IRTC | RVP | |
|---|---|---|
| RSI ODDS (%) | 4 days ago 81% | 4 days ago 82% |
| Stochastic ODDS (%) | 4 days ago 77% | 4 days ago 78% |
| Momentum ODDS (%) | 4 days ago 83% | 4 days ago 77% |
| MACD ODDS (%) | 4 days ago 79% | N/A |
| TrendWeek ODDS (%) | 4 days ago 78% | 4 days ago 81% |
| TrendMonth ODDS (%) | 4 days ago 80% | 4 days ago 80% |
| Advances ODDS (%) | 5 days ago 79% | 14 days ago 67% |
| Declines ODDS (%) | 26 days ago 80% | 4 days ago 82% |
| BollingerBands ODDS (%) | 4 days ago 82% | 4 days ago 76% |
| Aroon ODDS (%) | 4 days ago 81% | 4 days ago 81% |
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
IRTC’s FA Score shows that 1 FA rating(s) are green while RVP’s FA Score has 2 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
IRTC’s TA Score shows that 5 TA indicator(s) are bullish while RVP’s TA Score has 4 bullish TA indicator(s).
IRTC (@Medical/Nursing Services) experienced а +1.73% price change this week, while RVP (@Pharmaceuticals: Other) price change was -2.77% for the same time period.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was +0.62%. For the same industry, the average monthly price growth was -6.73%, and the average quarterly price growth was -7.68%.
The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -0.32%. For the same industry, the average monthly price growth was -1.69%, and the average quarterly price growth was +11.66%.
IRTC is expected to report earnings on Nov 05, 2026.
RVP is expected to report earnings on Nov 13, 2026.
The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
@Pharmaceuticals: Other (-0.32% weekly)Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.
A.I.dvisor indicates that over the last year, IRTC has been loosely correlated with STE. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if IRTC jumps, then STE could also see price increases.
| Ticker / NAME | Correlation To IRTC | 1D Price Change % | ||
|---|---|---|---|---|
| IRTC | 100% | -3.47% | ||
| STE - IRTC | 45% Loosely correlated | -2.16% | ||
| GEHC - IRTC | 41% Loosely correlated | +0.20% | ||
| INGN - IRTC | 39% Loosely correlated | -5.51% | ||
| LIVN - IRTC | 39% Loosely correlated | -2.81% | ||
| SYK - IRTC | 39% Loosely correlated | -6.38% | ||
More | ||||
A.I.dvisor tells us that RVP and IART have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that RVP and IART's prices will move in lockstep.
| Ticker / NAME | Correlation To RVP | 1D Price Change % | ||
|---|---|---|---|---|
| RVP | 100% | -1.96% | ||
| IART - RVP | 26% Poorly correlated | -0.62% | ||
| CVRX - RVP | 24% Poorly correlated | -1.05% | ||
| A - RVP | 22% Poorly correlated | -3.47% | ||
| CTKB - RVP | 22% Poorly correlated | -2.70% | ||
| IRTC - RVP | 22% Poorly correlated | -3.47% | ||
More | ||||
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| SLQD | 49.78 | 0.05 | +0.11% |
| iShares 0-5 Year Investment Grade Corporate Bond ETF (SLQD) | |||
| EPMV | 26.39 | N/A | N/A |
| Harbor Mid Cap Value ETF | |||
| FDAT | 21.91 | -0.33 | -1.49% |
| Tactical Advantage ETF (FDAT) | |||
| LRND | 44.74 | -1.26 | -2.75% |
| NYLIM U.S. Large Cap R&D Leaders ETF (LRND) | |||
| ASTX | 4.24 | -0.47 | -9.98% |
| Tradr 2X Long ASTS Daily ETF (ASTX) | |||